Principia Biopharma Inc.

Patents = 51

Trademarks = 22

Forward Citations = 326

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

47 inventors (with patents filed for the assignee):

Principia Biopharma Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel therapies for immune-mediated diseases. With their proprietary Tailored Covalency platform, they design and optimize small molecule drugs that target specific proteins involved in various autoimmune disorders, inflammatory diseases, and oncology indications. Principia Biopharma aims to provide effective and safe treatment options to patients through their innovative and precise approach to drug development.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com